Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial
- 31 December 2009
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 10 (12), 1160-1170
- https://doi.org/10.1016/s1470-2045(09)70258-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's DiseaseNew England Journal of Medicine, 2007
- Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: A population-based studyEuropean Journal of Cancer, 2006
- Quality of life in long-term Hodgkin’s disease survivors with chronic fatigueEuropean Journal of Cancer, 2006
- A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigueAnnals Of Oncology, 2005
- Health Status and Quality of Life in Patients With Early-Stage Hodgkin’s Disease Treated on Southwest Oncology Group Study 9133Journal of Clinical Oncology, 2003
- Fatigue in the Danish general population. Influence of sociodemographic factors and diseaseJournal of Epidemiology and Community Health, 2000
- Quality of life assessment in Hodgkin’s disease: A new comprehensive approachAnnals of Oncology, 1998
- Using reference data on quality of life—the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3)European Journal Of Cancer, 1998
- The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigueJournal of Psychosomatic Research, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993